Compass Capital Management Inc. bought a new position in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) during the 3rd quarter, Holdings Channel reports. The institutional investor bought 423,049 shares of the pharmacy operator’s stock, valued at approximately $30,840,000. Walgreens Boots Alliance accounts for approximately 4.0% of Compass Capital Management Inc.’s holdings, making the stock its 8th biggest position.
Other large investors have also recently made changes to their positions in the company. Anchor Capital Advisors LLC bought a new position in shares of Walgreens Boots Alliance in the third quarter valued at $219,000. Moody National Bank Trust Division increased its holdings in shares of Walgreens Boots Alliance by 1,416.3% in the third quarter. Moody National Bank Trust Division now owns 90,311 shares of the pharmacy operator’s stock valued at $6,583,000 after buying an additional 84,355 shares in the last quarter. Steinberg Global Asset Management bought a new position in shares of Walgreens Boots Alliance in the third quarter valued at $212,000. Accuvest Global Advisors bought a new position in shares of Walgreens Boots Alliance in the third quarter valued at $477,000. Finally, Robeco Institutional Asset Management B.V. increased its holdings in shares of Walgreens Boots Alliance by 12.6% in the third quarter. Robeco Institutional Asset Management B.V. now owns 589,231 shares of the pharmacy operator’s stock valued at $42,955,000 after buying an additional 66,124 shares in the last quarter. 64.81% of the stock is currently owned by hedge funds and other institutional investors.
Shares of NASDAQ:WBA opened at $79.30 on Friday. The company has a debt-to-equity ratio of 0.47, a quick ratio of 0.38 and a current ratio of 0.82. Walgreens Boots Alliance Inc has a 12-month low of $59.07 and a 12-month high of $80.68. The firm has a market cap of $74.79 billion, a price-to-earnings ratio of 13.17, a PEG ratio of 1.23 and a beta of 1.04.
Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Thursday, October 11th. The pharmacy operator reported $1.48 EPS for the quarter, beating the consensus estimate of $1.45 by $0.03. Walgreens Boots Alliance had a net margin of 3.82% and a return on equity of 21.75%. The business had revenue of $33.44 billion for the quarter, compared to analysts’ expectations of $33.64 billion. On average, sell-side analysts forecast that Walgreens Boots Alliance Inc will post 6.54 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Wednesday, December 12th. Stockholders of record on Monday, November 12th will be issued a dividend of $0.44 per share. This represents a $1.76 annualized dividend and a dividend yield of 2.22%. The ex-dividend date is Thursday, November 8th. Walgreens Boots Alliance’s dividend payout ratio is currently 29.24%.
In other news, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction on Thursday, November 1st. The shares were sold at an average price of $79.48, for a total transaction of $217,457.28. Following the transaction, the director now directly owns 8,207 shares in the company, valued at approximately $652,292.36. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, SVP Kimberly R. Scardino sold 11,970 shares of the business’s stock in a transaction on Thursday, November 1st. The shares were sold at an average price of $79.79, for a total transaction of $955,086.30. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 66,706 shares of company stock worth $5,268,584. 14.80% of the stock is currently owned by corporate insiders.
Several research analysts have issued reports on WBA shares. Zacks Investment Research raised Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $79.00 price target on the stock in a report on Saturday, October 13th. Citigroup downgraded shares of Walgreens Boots Alliance from a “buy” rating to a “neutral” rating and set a $69.00 target price on the stock. in a research note on Monday, July 9th. BidaskClub downgraded shares of Walgreens Boots Alliance from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, August 28th. Robert W. Baird boosted their target price on shares of Walgreens Boots Alliance from $69.00 to $71.00 and gave the company a “neutral” rating in a research note on Friday, October 12th. Finally, Barclays boosted their target price on shares of Walgreens Boots Alliance from $77.00 to $80.00 and gave the company an “equal weight” rating in a research note on Friday, October 12th. One research analyst has rated the stock with a sell rating, eleven have given a hold rating, seven have assigned a buy rating and two have given a strong buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus target price of $78.22.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.
Featured Article: Day Trading
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.